The mean serum glucose levels for the apoE−/− mice with 6 weeks of diabetes and prior to insulin treatment were 364 ± 66 mg/dL for the mice that received the insulin implants and 360 ± 57 mg/dL for the mice that were followed as hyperglycemic controls. This evidence concerns the gene APOE and diabetes mellitus.